Then, these reduced phosphorylation levels of β-catenin led to increases in its endogenous level and downstream regulator expressions such as cyclin D1, suggesting that IGF-1 activated the WNT/β-catenin pathway in glioma U87-MG cells. The gene discussed is IGF1; the disease is central nervous system cancer.